Ads
related to: catalyst pharmaceutical
Search results
Is Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Recent Stock Performance Tethered To Its Strong...
Simply Wall St. via Yahoo Finance· 5 months agoCatalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up by...
Catalyst Pharmaceuticals: An Attractive Biopharma Bet
GuruFocus.com via Yahoo Finance· 4 months agoCatalyst Pharmaceuticals Inc. (NASDAQ:CPRX) is an attractive biopharma stock to own, given the niche...
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up by...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 weeks agoCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Catalyst...
Zacks Industry Outlook Highlights Jazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie...
Zacks via Yahoo Finance· 2 years agoJazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie Pharmaceuticals, Larimar Therapeutics and...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who...
Simply Wall St. via Yahoo Finance· 2 months agoKey Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock...
Insider Sell Alert: Director David Tierney Sells 50,000 Shares of Catalyst Pharmaceuticals Inc ...
GuruFocus.com via Yahoo Finance· 6 months agoIn a notable insider transaction, Director David Tierney of Catalyst Pharmaceuticals Inc...
Here's Why Catalyst Pharmaceuticals (NASDAQ:CPRX) Has Caught The Eye Of Investors
Simply Wall St. via Yahoo Finance· 2 years agoIt's common for many investors, especially those who are inexperienced, to buy shares in companies...
Catalyst Pharmaceuticals (CPRX) to Post Q3 Earnings: What's Up?
Zacks via Yahoo Finance· 2 years agoOn Catalyst Pharmaceuticals' (CPRX) third-quarter earnings call, investors will likely focus on the...
Catalyst Pharmaceuticals Second Quarter 2023 Earnings: EPS: US$0.35 (vs US$0.21 in 2Q 2022)
Simply Wall St. via Yahoo Finance· 10 months agoCatalyst Pharmaceuticals (NASDAQ:CPRX) Second Quarter 2023 Results Key Financial Results Revenue:...
